Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M, Wais V, Sala E, Neagoie A, Nguyen TM, Gantner A, von Harsdorf S, Kuchenbauer F, Schubert A, Michel D, Döhner H, Bunjes D. Akhmedov M, et al. Among authors: wais v. Transpl Infect Dis. 2020 Aug;22(4):e13276. doi: 10.1111/tid.13276. Epub 2020 Apr 6. Transpl Infect Dis. 2020. PMID: 32162389
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation.
Hütter-Krönke ML, Neagoie A, Blau IW, Wais V, Vuong L, Gantner A, Ahn J, Penack O, Schnell J, Nogai KA, Eberspächer B, Saadati M, Benner A, Bullinger L, Döhner H, Bunjes D, Sala E. Hütter-Krönke ML, et al. Among authors: wais v. Front Immunol. 2023 May 3;14:1174289. doi: 10.3389/fimmu.2023.1174289. eCollection 2023. Front Immunol. 2023. PMID: 37207199 Free PMC article.
Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients - a pilot study for novel biomarker and risk stratification determination.
Schulz SVW, Bizjak DA, Moebes E, John L, Wais V, Bunjes D, Sala E, Steinacker JM, Kirsten J. Schulz SVW, et al. Among authors: wais v. Front Immunol. 2023 May 15;14:1129687. doi: 10.3389/fimmu.2023.1129687. eCollection 2023. Front Immunol. 2023. PMID: 37256146 Free PMC article.
Granulocyte transfusions - bridging to allogeneic hematopoietic stem cell transplantation.
Nguyen TM, Scholl K, Idler I, Wais V, Körper S, Lotfi R, Bommer M, Wiesneth M, Schrezenmeier H, Döhner H, Bohl SR, Harsdorf SV, Reinhardt P, Bunjes D, Ringhoffer M, Kuchenbauer F. Nguyen TM, et al. Among authors: wais v. Leuk Lymphoma. 2020 Feb;61(2):481-484. doi: 10.1080/10428194.2019.1660977. Epub 2019 Sep 24. Leuk Lymphoma. 2020. PMID: 31547738 No abstract available.
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT.
Bohl S, von Harsdorf S, Mulaw M, Hofmann S, Babiak A, Maier CP, Schnell J, Hütter-Krönke LM, Scholl K, Wais V, Schlenk RF, Bullinger L, Ringhoffer M, Döhner H, Bunjes D, Bommer M, Kuchenbauer F. Bohl S, et al. Among authors: wais v. Bone Marrow Transplant. 2016 Jul;51(7):994-6. doi: 10.1038/bmt.2016.4. Epub 2016 Mar 7. Bone Marrow Transplant. 2016. PMID: 26950380 Free PMC article. No abstract available.
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.
Wais V, Kündgen L, Bohl SR, von Harsdorf S, Schlenk RF, Döhner K, Teleanu V, Bullinger L, Nguyen TM, Drognitz K, Moulin JC, Binnenhei M, Bentz M, Döhner H, Bunjes D, Kuchenbauer F, Ringhoffer M. Wais V, et al. Bone Marrow Transplant. 2018 Jan;53(1):94-96. doi: 10.1038/bmt.2017.211. Epub 2017 Nov 13. Bone Marrow Transplant. 2018. PMID: 29131153 No abstract available.
21 results